UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MAXCYTE INC ownership

MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 120 filers reported holding MAXCYTE INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of MAXCYTE INC
ValueSharesWeighting
Q2 2024$904,575
+45.9%
230,759
+56.0%
0.00%
Q1 2024$619,943
-10.9%
147,9580.0%0.00%
Q4 2023$695,403
+50.6%
147,9580.0%0.00%
Q3 2023$461,628
+49.9%
147,958
+137.8%
0.00%
Q2 2023$307,9540.0%62,2130.0%0.00%
Q1 2023$307,954
-10.3%
62,213
-1.1%
0.00%
Q4 2022$343,434
-99.9%
62,9000.0%0.00%
Q3 2022$408,850,000
+37.4%
62,9000.0%0.00%
Q2 2022$297,517,000
-7.5%
62,900
+36.7%
0.00%
Q1 2022$321,540,000
-31.4%
46,0000.0%0.00%
Q4 2021$468,740,00046,0000.00%
Other shareholders
MAXCYTE INC shareholders Q4 2023
NameSharesValueWeighting ↓
Casdin Capital, LLC 13,971,334$142,368,0004.01%
APIS CAPITAL ADVISORS, LLC 220,000$2,242,0002.48%
Nine Ten Capital Management LLC 1,868,597$19,041,0001.98%
RIVER GLOBAL INVESTORS LLP 2,415,500$24,702,0001.93%
Vitruvian Partners LLP 3,330,000$33,933,0001.77%
Montanaro Asset Management Ltd 1,379,000$14,080,0001.42%
Pier Capital, LLC 1,024,251$10,437,0001.10%
First Light Asset Management, LLC 1,232,277$12,557,0000.90%
Nicholas Investment Partners, LP 986,301$10,050,0000.64%
Bleichroeder LP 250,000$2,538,0000.40%
View complete list of MAXCYTE INC shareholders